Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020

By October 2021, 230 million SARS-CoV-2 diagnoses have been reported. Yet, a considerable proportion of cases remains undetected. Here, we propose GInPipe, a method that rapidly reconstructs SARS-CoV-2 incidence profiles solely from publicly available, time-stamped viral genomes. We validate GInPipe against simulated outbreaks and elaborate phylodynamic analyses. Using available sequence data, we reconstruct incidence histories for Denmark, Scotland, Switzerland, and Victoria (Australia) and demonstrate, how to use the method to investigate the effects of changing testing policies on case ascertainment. Specifically, we find that under-reporting was highest during summer 2020 in Europe, coinciding with more liberal testing policies at times of low testing capacities. Due to the increased use of real-time sequencing, it is envisaged that GInPipe can complement established surveillance tools to monitor the SARS-CoV-2 pandemic. In post-pandemic times, when diagnostic efforts are decreasing, GInPipe may facilitate the detection of hidden infection dynamics.

Abstract licence: CC BY-NC-ND

1. 8.

   BEAST 2: A Software Platform for Bayesian Evolutionary Analysis · 2014

2. 15.

   Viral phylodynamics and the search for an ‘effective number of infections’ · 2010

3. 22.

   The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks · 2012

4. 34.

   Data, disease and diplomacy: GISAID's innovative contribution to global health · 2017

5. 35.

   GISAID: Global initiative on sharing all influenza data – from vision to reality · 2017

6. 37.

   Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7 · 2018

34 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.